Navigation Links
Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease
Date:6/15/2011

ersible perfusion defects of comparable size at one year following these procedures.

An independent long-term study published in Circulation (Meier et al, Circ. 2007; 116:975-983) provided key evidence indicating that men and women with more recruitable collateral circulation have a better chance of surviving a heart attack than patients who have less developed collateral circulation.  This important study quantitatively evaluated coronary collateral blood flow in 845 patients with coronary artery disease during a 10-year follow-up period and showed that long-term cardiac mortality was approximately 66% lower in patients with a highly developed collateral vessel blood supply (p=0.019).  For the first time, this study showed the importance of collateral circulation beyond simply the relief of angina and provided further support of the potential for long term benefits from angiogenic therapy.

"We are pleased to receive clearance from the Russian Ministry of Health and Social Development and look forward to initiating our ASPIRE study with the assistance of the bioRASI organization.  From a global perspective, it is expected that over 80% of the future increase in coronary heart disease mortality will occur outside the U.S., and the economic burden of heart disease is no longer confined to the industrialized world.  With the exception of sub-Saharan Africa, cardiovascular disease is the leading cause of death in the developing world as a result of accelerating tobacco use, diet and lifestyle changes.  There is a need for innovative and cost-effective advanced cardiovascular care to meet the accelerating levels of cardiovascular disease affecting global markets.  A new video "Cardium Generx Cardio-Chant" provides an overview of our Generx product candidate at http://www.youtube.com/watch?v=pjUndFhJkjM.  We believe that Generx may offer the potential fo
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
2. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
3. deCODE Launches a DNA-Based Test for Assessing Risk of Prostate Cancer on the Back of the Discovery of New Prostate Cancer Genes
4. SF1126, Semafores PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines
5. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
6. Semafores SF1126 Exhibits Antitumor and Antiangiogenic Activity
7. Multiple Presentations Confirm Clinical Efficacy and High Rate of Patient Compliance Using Provent® Sleep Apnea Therapy to Treat Obstructive Sleep Apnea
8. Dry Eye Therapy Utilizing Cationic Novasorb® Technology Available Soon From OCuSOFT®
9. Accuray Successfully Completes Acquisition of TomoTherapy
10. Vertex Plans to Provide Access to Potential CF Therapy VX-770 for Patients with Critical Medical Need
11. TomoTherapy Shareholders Approve Accuray Acquisition of TomoTherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Research and Markets( http://www.researchandmarkets.com/research/hxhwtv/asia_pacific ) has announced ... - Growth, Trends And Forecasts (2014 - 2019)" ... Asia Pacific market for Fluoroscopy is ... to 2020 Fluoroscopy is the imaging technology ... the interior of the body. The imaging team consists ...
(Date:5/27/2015)... May 27, 2015 ... du décalage horaire. Il nuit sérieusement à ... concentration durant les réunions de mi-journée et ... au mauvais moment dans votre chambre d,hôtel. ... décalage horaire risque de vous empêcher de ...
(Date:5/27/2015)... Donatelli, a senior marketing associate with the animal health division of Eli ... a healthcare setting in Bangkok, Thailand , will be ... need with respect and dignity is the guiding star for me and ... in a LillyPad blog . Donatelli and Lilly colleagues ... Colombia , France , Ukraine ...
Breaking Medicine Technology:Asia Pacific Fluoroscopy Market Trends and Forecasts 2014 - 2019 2HumanCharger, l'allié des sportifs d'élite, vous aide à vaincre le décalage horaire deux fois plus vite 2HumanCharger, l'allié des sportifs d'élite, vous aide à vaincre le décalage horaire deux fois plus vite 3HumanCharger, l'allié des sportifs d'élite, vous aide à vaincre le décalage horaire deux fois plus vite 4Lilly Sends Employees to Serve in Vulnerable Communities around the World 2Lilly Sends Employees to Serve in Vulnerable Communities around the World 3
... Decas SDCs Offer Greater Amounts of the Natural Compound Responsible ... Antioxidant and Anti-adhesion ... Inc.,announced today the results of new research showing that 1 ... has twice the,proanthocyanidin (PAC) level of an 8-ounce glass of ...
... MATEO, Calif., Dec. 12 BioForm Medical,Inc. (Nasdaq: ... a multi-center,randomized, blinded comparative study of nasolabial fold ... filler,than reported after treatment with either Juvederm(TM) or ... the December 2007 Filler Issue of,the Journal of ...
Cached Medicine Technology:Research Shows Decas Sweetened Dried Cranberries Pack Twice the Proanthocyanidin Punch as Cranberry Juice Cocktail 2Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 2Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 3Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 4Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 5Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 6
(Date:5/27/2015)... “ Nursing Homes are starting to supplant hospitals ... of a recent April 2015 New York Times article. While ... the hospital, 20-plus years of research have documented the risks ... nursing homes are both safer for older patients and less ... homes varying widely, patients and family members may worry whether ...
(Date:5/27/2015)... May 27, 2015 In today's healthcare ... tighter, it can be challenging for doctors and hospitals ... edge treatments. , Austin-based HealthTronics, Inc. ... invasive, mobile medical therapies for clinically sophisticated applications. The ... the acquisition of Laser Ventures, Inc ., a ...
(Date:5/27/2015)... Black Book Rankings, well known ... the multiple services and software industries, conducted a ... ranked Electronic Health and Medical Record software systems ... focus on implemented EHR users, Black Book reveals ... the highest scores in client experience among small ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 SAN ... in Gulfport Mississippi, is the first healthcare provider ... approach to chronic care management (CCM). In partnership ... Memorial is introducing RevUp, a new program that ... requirements and increase monthly reimbursements. This new, user-friendly ...
(Date:5/27/2015)... Cincinnati Veterans Affairs Women’s Health Clinic in partnership with ... proud to host the first annual Women Veterans awards ... the Freedom Center from 6 p.m. to 10 p.m. ... , This event honors and celebrates women tri-state Veterans for ... is free to the first 150 women Veterans who register ...
Breaking Medicine News(10 mins):Health News:BestNursingHomes.com Launches on National Senior Health and Fitness Day 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 4Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 2Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 3Health News:Cincinnati VA Women’s Health Clinic Celebrates Women Veterans at Awards Banquet 2
... Southwestern Medical Center have determined that the level, or saturation, ... with sickle cell anemia who are at an increased risk ... also found that a published method used to predict severe ... Stroke is a serious but increasingly preventable complication of sickle ...
... cash flow from operations achieved for Q4 and the ... AMCS ),a leader in radiology and medical image ... the fourth,quarter and year ended December 31, 2007., ... Q4 Financial Highlights Revenue: Total revenues for ...
... Investigation into allergic reactions, deaths related to blood thinner ... Healthcare Corp., the pharmaceutical company at the center of ... that it was recalling any remaining multi-dose vials of ... company also said it was recalling its Hep-Lock heparin ...
... to Reliance on Spill-Proof,Cups, GLENDALE, Calif., Feb. 28 ... Dental Hygienists, Association,(CDHA) today urged parents and caregivers to ... "We all know that sippy cups are a godsend ... "But they need to be used wisely and,properly in ...
... The Board of Directors of,Belden (NYSE: BDC ... and member of,the Compensation Committee of the board. Ms. ... Resources at Pfizer Inc., a post she has held,since ... world,s largest global,research-based pharmaceutical company. Prior to joining Pfizer, ...
... Changes in standards support Department of Health ... improvement, WASHINGTON, Feb. 28 Today ... its Core Accreditation standards. The Core,standards are ... functions within health care organization such as ...
Cached Medicine News:Health News:UT Southwestern researchers investigate predictors for sickle-cell-anemia complications 2Health News:AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 2Health News:AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 3Health News:AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 4Health News:AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 5Health News:AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 6Health News:AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 7Health News:AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 8Health News:AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 9Health News:AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 10Health News:AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 11Health News:Baxter Recalls Rest of Heparin Products 2Health News:Baxter Recalls Rest of Heparin Products 3Health News:California Dental Hygienists Offer Tips for Safe Sippy Cup Use 2Health News:Belden Appoints Mary S. McLeod of Pfizer Inc. to Board of Directors 2Health News:URAC Invites Health Management Industry, Public for Comments on Changes to Its Core Accreditation Standards 2Health News:URAC Invites Health Management Industry, Public for Comments on Changes to Its Core Accreditation Standards 3
Sebia's Hb AFSC Control provides excellent resolution of normal hemoglobins A & F and abnormal hemoglobins S & C. The control is designed for use with Sebia's Hydragel Hemoglobin and Hydragel Acid He...
The HYRYS™ 2 densitometer is reflective of Sebia's expertise in the development and design of imaging systems and densitometers utilized in the electrophoresis field....
Eliminating the need for any manual pipetting, the HydraPLUS delivers precise micro-volumes of sample directly from primary tubes to four HYDRASYS sample applicators contained in a built-in humidity ...
Inquire...
Medicine Products: